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Accepted 2 November 2017Background: N-terminal pro-brain natriuretic peptide (NT-proBNP) and high sensitivity Troponin T (hsTnT) are
markers of cardiac injury used in diagnosis of heart failure andmyocardial infarction respectively, and associated
with increased risk of cardiovascular disease. Since physical activity is protective against cardiovascular disease
and heart failure, we investigated whether higher levels of physical activity, and less sedentary behaviour
were associated with lower NT-proBNP and hsTnT.
Methods and results: Cross sectional study of 1130 men, age 70–91 years, from the British Regional Heart Study,
measured in 2010–2012. Fasting blood samples were analysed for NT-proBNP and hsTnT. Physical activity and
sedentary behaviour were measured using ActiGraph GT3X accelerometers. Relationships between activity
and NT-proBNP or hsTnT were non-linear; biomarker levels were lower with higher total activity, steps, moder-
ate/vigorous activity and light activity only at low to moderate levels of activity. For example, for each additional
10min of moderate/vigorous activity, NT-proBNPwas lower by 35.7% (95% CI−47.9,−23.6) and hsTnT by 8.4%
(95% CI -11.1,−5.6), in men who undertook b25 or 50 min of moderate/vigorous activity per day respectively.
Biomarker levels increased linearly with increasing sedentary behaviour, but not independently of moderate/
vigorous activity.
Conclusion: Associations between biomarkers and moderate/vigorous activity (and between hsTnT and light
activity) were independent of sedentary behaviour, suggesting activity is driving the relationships. In these
older men with concomitantly low levels of physical activity, activity may be more important in protecting
against cardiac health deterioration in less active individuals, although reverse causality might be operating.
© 2017 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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Men1. Introduction
N-terminal pro-brain natriuretic peptide (NT-proBNP) and high sen-
sitivity Troponin T (hsTnT) are routinely measured clinical biomarkers.
Although the biologically active natriuretic peptides have protective
diuretic, natriuretic, and metabolic effects, elevated NT-proBNP is used
in the diagnosis and monitoring of heart failure [1], and is a strong
marker of ventricular stretch and cardiac overload. In contrast hsTnT
is a marker ofmyocardial ischaemia used in the diagnosis of myocardial
infarction [2]. In observational studies both are associated with
increased risk of cardiovascular disease and all-cause mortality, overCare & Population Health, UCL
ited Kingdom.
eliability and freedom from bias
land Ltd. This is an open access articland above other routine risk factors, even in apparently healthy people
[3–6]. Importantly, both biomarkers have been shown to predict cardio-
vascular events [6], and it has been recently suggested that NTproBNP
assessment could integrate heart failure into CVD primary prevention [7].
Two recent systematic reviews have reported that physical activity
is protective against incident heart failure [8,9], and a number of studies
suggest that the beneﬁts are greater at or conﬁned to higher levels of
physical activity [9]. Physical activity improves many of the established
heart failure risk factors such as hypertension, obesity, diabetes,
smoking and coronary artery disease [10], and may also reduce the
age-related decline in cardiac structure and function [11]. Sedentary
behaviour, deﬁned as sitting or reclining as distinct from a low level of
physical activity has been little investigated in relation to heart failure
but there is some evidence that sedentary behaviour may increase
heart failure risk independently of physical activity [12].
Few studies have investigated relationships between physical activ-
ity and NT-proBNP or hsTnT, and ﬁndings are inconsistent. A study ofe under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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measured walking was associated with lower levels of NT-proBNP and
hsTnT [13], whilst of two studies using self-reported measures of
physical activity, one found that participants doing more activity were
less likely to experience an increase in NT-proBNP or hsTnT level during
follow up [14], and the other found no associations between physical
activity and biomarkers [15]. Self-report data for physical activity has
limitations, particularly for light activity and sedentary behaviour and
in older adults who have lower levels of physical activity and are more
sedentary [16]. We investigated associations between both objectively
measured physical activity and sedentary behaviour and biomarkers
NT-proBNP and hsTnT, in a sample of community dwelling older men.
2. Methods
2.1. Sample
The British Regional Heart Study is a population-based cohort study following 7735
men recruited from primary care practices in 24 British towns in 1978–80. In 2010–
2012, 3137 survivorswere invited to (i) a physical examination,which included providing
a fasting blood sample and (ii)wear a physical activitymonitor. 1722men (55%) attended,
1603 of whom provided a blood sample with NT-proBNP and hsTnT levels analysed. We
excluded 272 men with a reported diagnosis of heart attack, heart failure, or stroke,
leaving 1331 men with biomarker data. The National Research Ethics Service (NRES)
Committee London provided ethical approval. Participants provided informed written
consent to the investigation in accordance with the Declaration of Helsinki.
2.2. Objective physical activity assessment
Men wore the GT3X accelerometer (Actigraph, Pensacola, Florida) over the right hip
for 7 days, during waking hours, removing it for swimming or bathing. Counts per minute
(CPM) were calculated frommovements registering on the vertical axis. Data were proc-
essed using standard methods [17]. Non-wear time was excluded using the R package
“Physical Activity” [18]. Valid wear days were deﬁned by convention as ≥600 min wear
time, and participants with ≥3 valid days were included in analyses. Each minute of
activitywas categorised usingwidely used intensity threshold values of counts perminute
developed for older adults: b100 for sedentary behaviour (b1.5 MET), 100–1040 for light
activity (1.5–3 MET) and N1040 for moderate/vigorous activity,(≥3 MET) [19].
2.3. Cardiac injury biomarkers
Menwere requested to fast for at least 6 h and instructed to drink onlywater during this
time and take medications as usual. Blood samples were collected between 08:00 h and
19:00 h, centrifuged and separated the same day and stored on site at−20 °C until they
were transferred (within 2 weeks) to a central freezer storage location at−70 °C. Samples
were subsequently transferred to a central laboratory on dry ice and thawed immediately
prior to analysis. NT-proBNP andhsTnTweremeasured using electrochemiluminescence im-
munoassays, performed on a Roche Elecsys 2010 automated platform (Roche Diagnostics,
Burgess Hill, UK). The NT-proBNP and hsTnT assays have lower detection limits of 5 pg/mL
and 3 ng/L, respectively [20,21]. For both assays, results below the limit of detection were
assigned a value of 50% of the functional limit of detection (2.5 pg/mL for NT-proBNP and
1.5 ng/L for hsTnT). Assays were performed using the manufacturer's calibrators and quality
controls. NT-proBNP andhsTnThad assay coefﬁcients of variationof 6.5% and4.5% for the low
control and 3.8% and 9.1% for the high control, respectively.
2.4. Covariates
Men completed a questionnaire including information about: current cigarette
smoking, alcohol consumption, living alone, current use of antihypertensives, statins and
anticoagulants, ever receiving a doctor diagnosis of heart attack, heart failure, and stroke
(with symptoms lasting N24 h). Social class was based on longest held occupation at
study entry (1978–80) and categorised as manual and non-manual. Region of residence
(1978–80) was grouped into Scotland, North, Midlands and South of England. Body
mass index (BMI, kg/m2) was calculated from height (Harpenden stadiometer) and
weight in light indoor clothing (Tanita body composition analyser (BC-418) or Tanita
scales if the participant had a pacemaker or deﬁbrillator).
2.5. Statistical methods
We excluded men reporting a diagnosis of heart attack, heart failure, or stroke (with
symptoms lasting N24 h) from analyses. Descriptive statistics for social and demographic
characteristics, physical activity and sedentary behaviour, were calculated by quartile of
NT-proBNP and hsTnT levels. The distributions of NT-proBNP and hsTnT were skewed
and therefore transformed using natural logarithm.
We investigated associations between a number of physical activity measures and
NT-proBNP or hsTnT. Physical activity measures included total activity counts per day,
steps per day, minutes per day of moderate and vigorous activity, light activity andsedentary behaviour. We ﬁrst used generalised additive models (GAMs) to investigate
whether the relationships between each physical activity measure and NT-proBNP or
hsTnT were nonlinear, using the “mgcv” package in R (version 3.0.3). GAM is a non-para-
metric model that does not specify the shape of any nonlinearity. To quantify associations
between physical activity and NT-proBNP/hsTnT we used linear regression models (Stata
version 13), and where associations were nonlinear we used the Stata function
“mkspline”. Mkspline allows the relationship to be estimated as a piecewise linear func-
tion (a function composed of linear segments), joining at knots. The position of the
knot(s) (turning point of the function) was estimated from the GAM plots. All models
were adjusted for average accelerometer wear time (minutes/day), season of accelerom-
eter wear (warm, May–September or cold, October–April), hour of blood sampling, age,
region of residence, social class, living alone, smoking status and alcohol. For ease of inter-
pretationwepresent percentage differences in biomarker levels for each additional 10,000
counts of total activity, 1000 steps, 30 min of sedentary behaviour or light activity and
10 min of moderate/vigorous activity per day. To evaluate the independence of associa-
tions of activity intensities,modelsweremutually adjusted; (i)moderate/vigorous activity
and sedentary behaviour and (ii)moderate/vigorous activity and light activity in the same
model. Sedentary behaviour and light activity were not included in the samemodel due to
collinearity (r=−0.62). We further adjusted all models for BMI to investigate whether
BMI modiﬁed relationships between physical activity/sedentary behaviour and the bio-
markers. To explore the potential of undiagnosed heart failure inﬂuencing ﬁndingswe re-
peated regressionmodels after excludingmenwithNTproBNP N400 pg/L.We conducted a
post hoc analysis to investigate whether baseline levels of biomarkers and their associa-
tion with physical activity differed by hypertensive status.
3. Results
Of 1331 men with biomarker levels available, 45 had an undetect-
able level of NT-proBNP (allocated value 2.5 pg/L) and 38 men had un-
detectable hsTnT (allocated value 1.5 ng/L). 1130 men had data for
biomarkers, physical activity and all covariates. Men spent on average
614, 200 and 41 min per day in sedentary behaviour, light activity and
moderate/vigorous activity respectively, had a mean of 5004 steps and
167,397 accelerometer counts per day (Table 1). Eighty percent of
men had 7 days of accelerometer data and 96% had ≥5 days of data.
Men with higher levels of NT-proBNP or hsTnT were older, more likely
to live alone, take statins or anti-hypertensive medication, consume
less alcohol, have lower levels of physical activity and higher levels of
sedentary behaviour (Tables 1 & 2). Men with higher levels of hsTnT
were also more likely to have diabetes (Table 2).
Generalised additivemodels showed thatmenwho spentmore time
in physical activity had lower levels of NTproBNP and hsTnT, but rela-
tionshipswere non-linear and signiﬁcant only at lower levels of physical
activity, as illustrated by daily steps in Fig. 1, panels A and C. Total
counts, moderate/vigorous activity and light activity each showed a
similar pattern (not presented). In contrast, men who spent more
time in sedentary behaviour had higher levels of NTproBNP and hsTnT
and these associations were linear, as illustrated by daily steps in
Fig. 1, panels B and D.
Results from regression models including a spline, are given in
Table 3. Higher levels of physical activity were associated with lower
levels of NT-proBNP, but signiﬁcantly only below 150,000 counts per
day, 4000 steps per day, 25 min of moderate/vigorous activity per day
and 3 h of light activity per day, whereas associations above these
knots were not signiﬁcant (Table 3). For example, in men who under-
took b25 min of moderate/vigorous activity per day, NT-proBNP was
35.7% lower (95% CI−47.9,−23.6) for each additional 10 min of mod-
erate/vigorous activity (Table 3,Model 3). For each of the physical activ-
ity measures, coefﬁcients above and below the knots were signiﬁcantly
different from each other, p b 0.05.
Similarly, higher levels of physical activity were associated with
lower levels of hsTnT, but associations were signiﬁcant only below the
daily levels of counts, steps, moderate/vigorous activity and light
activity indicated in Table 3. For example, in men who undertook
b6000 steps per day, hsTnT was 10.0% lower (95% CI−12.9,−7.2) for
each additional 1000 steps, but there was no signiﬁcant association
above 6000 steps per day (Table 3, Model 2).
Associations between sedentary behaviour and cardiac injury
markers were linear and in the opposite direction. For each additional
30 min of sedentary behaviour, NT-proBNP levels were 6.3% higher
Table 1
Characteristics of 1331 men without pre-existing CVD or heart failure, by quartile of NTproBNP. Figures are mean (SD) unless stated otherwise.
Quartile of NTproBNP (pg/mL) P (trend) All men N
2.5–b68 ≥68–b134 ≥134–b312 ≥312–8322
Median = 39 Median = 98 Median = 198 Median = 619
(n= 362)a (n= 357)a (n= 329)a (n= 283)a
Age (years) 76.6 (3.8) 77.8 (4.1) 79.4 (4.7) 80.7 (5.2) b0.0001 78.5 (4.7) 1331
Manual social class,% (n) 49 (176) 46 (163) 44 (143) 43 (120) 0.4 46 (602) 1317
Lives alone,% (n) 15 (54) 19 (66) 23 (76) 22 (61) 0.03 20 (257) 1311
Smoker,% (n) 3.4 (12) 3.4 (12) 4.7 (15) 3.3 (9) 0.8 3.7 (48) 1308
Taking statins,% (n) 44 (159) 40 (144) 44 (146) 47 (134) 0.4 44 (583) 1331
Taking anti-hypertensives,% (n) 47 (170) 50 (178) 53 (175) 65 (184) b0.0001 53 (707) 1331
Taking anticoagulants,% (n) 0.8 (3) 2.8 (10) 2.7 (9) 19.8 (56) b0.0001 5.9 (78) 1331
Diabetic,% (n) 12 (45) 15 (52) 11 (36) 17 (49) 0.1 14 (182) 1331
Alcohol (units per week) 7.5 (8.3) 5.9 (7.1) 6.1 (7.4) 5.9 (7.5) 0.01 6.4 (7.6) 1296
BMI (kg/m2) 27.0 (3.7) 27.0 (3.9) 27.1 (3.6) 26.8 (3.9) 0.6 27.0 (3.8) 1319
Accelerometer wear time (min/day) 863 (70) 854 (69) 855 (61) 847 (64) 0.008 855 (67) 1184
Total activity (counts per day) 194,742 (102,400) 180,323 (102,384) 149,464 (93,570) 136,170 (90,943) b0.0001 167,397 (100,542) 1184
Steps/day 5813 (2775) 5351 (2883) 4550 (2672) 4040 (2556) b0.0001 5004 (2815) 1184
% time spent sedentary 69.9 (9.1) 70.8 (9.2) 73.2 (8.6) 74.7 (9.9) b0.0001 72 (9) 1184
% time light activity 24.4 (6.9) 24.1 (6.9) 22.7 (6.5) 21.6 (7.7) b0.0001 23 (7) 1184
% time moderate/vigorous activity 5.7 (4.0) 5.2 (3.6) 4.1 (3.5) 3.7 (3.5) b0.0001 4.7 (3.8) 1184
Sedentary behaviour (min/day) 603 (87) 602 (81) 625 (79) 631 (81) b0.0001 614 (83) 1184
Light activity (min/day) 211 (34) 207 (65) 194 (59) 185 (71) b0.0001 200 (65) 1184
Moderate/vigorous activity (min/day) 50 (34) 45 (32) 35 (32) 32 (31) b0.0001 41 (33) 1184
Pearson chi square test used for all categorical variables except smoking for which Fisher's exact test was used.
BMI, body mass index.
NT-proBNP, N-terminal pro-brain natriuretic peptide.
a Maximum N in quartile, varies slightly with missing covariate data.
324 T.J. Parsons et al. / International Journal of Cardiology 254 (2018) 322–327(95% CI 3.1, 9.4), and hsTnT 3.6% higher (95% CI 2.1, 5.2) (Table 3 Model
5). Associations between NT-proBNP or hsTnT and moderate/vigorous
activity were slightly reduced after adjusting for sedentary behaviour
(Table 3, Model 6), whilst associations with sedentary behaviour were
abolished. Associations between NT-proBNP or hsTnT and moderate/
vigorous activity were slightly reduced after adjusting for light activity
and although the association between NTproBNP and light activity
was abolished, that between hsTnT and light activity persisted albeitTable 2
Characteristics of 1331 men without pre-existing CVD or heart failure, by quartile of hsTNT. Fig
Quartile of hsTNT (ng/mL)
1.5–b7.26 ≥7.26–b11.34
Median = 5.34 Median = 9.23
(n= 348)a (n= 342)a
Age (years) 76.0 (3.4) 77.9 (4.2)
Manual social class,% (n) 48 (166) 46 (154)
Lives alone,% (n) 15 (52) 16 (54)
Smoker,% (n) 4.1 (14) 3.2 (11)
Taking statins,% (n) 40 (139) 47 (160)
Taking anti-hypertensives,% (n) 44 (152) 55 (187)
Taking anticoagulants,% (n) 2.0 (7) 4.4 (15)
Diabetic,% (n) 10 (34) 11 (38)
Alcohol (units per week) 6.9 (7.5) 6.4 (7.7)
BMI (kg/m2) 26.5 (3.6) 26.7 (3.6)
Accelerometer wear time (min/day) 857 (65) 864 (69)
Total activity (counts per day) 187,112 (90,810) 187,241 (99,061
Steps/day 5500 (2411) 5566 (3047)
% time spent sedentary 70.3 (8.5) 70.1 (9.1)
% time light activity 24.3 (6.7) 24.4 (6.5)
% time moderate/vigorous activity 5.4 (3.4) 5.5 (4.2)
Sedentary behaviour (min/day) 601 (78) 605 (85)
Light activity (min/day) 209 (63) 211 (60)
Moderate/vigorous activity (min/day) 47 (30) 47 (37)
Pearson chi square test used for all categorical variables except smoking for which Fisher's exa
BMI, body mass index.
Light activity, light physical activity.
hsTNT, high sensitivity Troponin T.
a Maximum N in quartile, varies slightly with missing covariate data.reduced in magnitude by about 40%. Adjusting models for BMI made
little difference to results.
After excluding 191 men with NTproBNP levels N400 pg/mL, associ-
ations between physical activity measures and NTproBNP or hsTnT
were reduced in magnitude but remained signiﬁcant except for associ-
ations between NTproBNP and light activity or sedentary behaviour
(details in Supplementary ﬁle). Post hoc analyses showed that men
with hypertension had higher levels of NTproBNP and hsTnT thanures are mean (SD) unless stated otherwise.
P (trend) N
≥11.34–b16.92 ≥16.92–407.10
Median = 13.40 Median = 23.33
(n= 332)a (n= 309)a
79.2 (4.7) 81.2 (4.8) b0.0001 1331
45 (148) 44 (134) 0.7 1317
20 (64) 29 (87) b0.0001 1311
4.0 (13) 3.3 (10) 0.9 1308
43 (144) 45 (140) 0.3 1331
50 (167) 65 (201) b0.0001 1331
6.0 (20) 11.7 (36) b0.0001 1331
15 (48) 21 (62) 0.001 1331
6.9 (8.1) 5.3 (7.1) 0.03 1296
27.4 (3.8) 27.4 (4.1) 0.001 1319
851 (63) 847 (69) 0.02 1184
) 165,126 (99,061) 122,935 (88,511) b0.0001 1184
4988 (2764) 3767 (2661) b0.0001 1184
71.7 (9.1) 76.4 (9.7) b0.0001 1184
23.6 (6.8) 20.5 (7.7) b0.0001 1184
4.7 (3.7) 3.2 (3.0) b0.0001 1184
609 (83) 644 (81) b0.0001 1184
201 (62) 175 (71) b0.0001 1184
40 (33) 27 (27) b0.0001 1184
ct test was used.
DC
BA
Fig. 1.Associations between cardiac biomarkers and physical activity/sedentary behaviour. Relationships between NT-proBNP and steps per day (panel A) and hours per day of sedentary
behaviour (panel B) and between hsTnT and steps per day (panel A) and daily hours of sedentary behaviour (panel B). Solid line represents smoothed function from the GAM, with 95% CI
(dotted lines), and p values are reported. Each model is adjusted for average daily accelerometer wear time, season of wear, hour of blood sampling, region of residence, age, social class,
living alone, tobacco, alcohol consumption.
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hypertensive status showed that associations between NTproBNP and
physical activity were present only in men with hypertension (see
Supplementary ﬁle). Associations between hsTnT and physical activity
did not differ by hypertensive status.
4. Discussion
In our study of British men from a seldom studied older age group
(71–90 years), we found that higher levels of physical activity were as-
sociated with lower levels of NT-proBNP and hsTnT, but the relation-
ships were non-linear and associations only seen at low to moderate
levels of activity. The shape of the relationship was similar for each of
the activity measures we investigated, total counts, steps, moderate/
vigorous activity and light activity. This non-linearity is consistent
with evidence that suggests that at most levels physical activity shows
beneﬁcial associations with cardiac biomarkers, structure and function,but at high levels physical activity can increase the release of BNP and
TnT, together with risks of CVD [22]. Sedentary behaviour was related
to NT-proBNP and hsTnT in the opposite direction; higher levels of
sedentary behaviour were associated with higher levels of NT-proBNP
and hsTnT, and these associations were linear.
Previously in this cohort when the men were aged 60–79 years,
higher self-reported physical activity was associated with lower
NT-proBNP [23] and there was some evidence that the beneﬁcial effects
of activity on CHD and all-cause mortality were mediated via a beneﬁ-
cial effect on NT-proBNP level. In addition, a 1 standard deviation (SD)
increase in loge NT-proBNP has been associatedwith an adjusted hazard
ratio (HR) formajor CVD events of 1.49 (95% CI 1.33, 1.65) and a 1SD in-
crease in loge hsTnT with an adjusted HR of 1.37 [24]. In our analyses,
among men taking b4000 steps per day, an additional 1000 steps per
day was associated with a decrease in loge NT-proBNP of 0.283, one
ﬁfth of 1SD (1.36), and extrapolating from earlier data might therefore
be associated with a HR of 0.9 for major CVD events. This is plausible
Table 3
Cross-sectional associations between physical activity intensity, sedentary behaviour, and markers of cardiac injury.
ln NT-proBNP
% difference
N= 1130
(95% CI)
ln hsTnT
% difference
N= 1130
(95% CI)
Model 1
Additional 10,000 vertical counts/day At b150,000 counts/day −7.5 (−10.0,−5.0) At b150,000 counts/day −4.3 (−5.5,−3.1)
At ≥150,000 counts/day 0.2 (−1.0, 1.3) At ≥150,000 counts/day 0.1 (−0.4, 0.7)
Model 2
Additional 1000 steps/day At b4000 steps/day −28.3 (−37.8,−18.9) At b6000 steps/day −10.0 (−12.9,−7.2)
At ≥4000 steps/day −1.9 (−5.8, 2.0) At 6000–b10,000 steps/day 1.5 (−2.6, 5.6)
At ≥10,000 steps 4.9 (−1.8, 11.6)
Model 3
Additional 10 min MVPA/day at b25 min MVPA/day −35.7 (−47.9,−23.6) At b50 min MVPA/day −8.4 (−11.1,−5.6)
at ≥25 min MVPA/day −0.3 (−3.3, 2.8) At 50–b130 min MVPA/day 1.5 (−1.0, 4.0)
At ≥130 min MVPA/day 2.3 (−8.3, 12.9)
Model 4
Additional 30 min LPA/day at b3 h LPA/day −19.5 (−28.7,−10.4) At b2.5 h LPA/day −15.5 (−21.8,−9.1)
at ≥3 h LPA/day −0.2 (−6.0, 5.5) At 2.5–b5 h LPA/day −1.4 (−4.2, 1.5)
At ≥5 h LPA/day −2.8 (−12.0, 6.4)
Model 5
Additional 30 min SB/day 6.3 (3.1, 9.4) 3.6 (2.1, 5.2)
Model 6
Additional 10 min MVPA/day at b25 min MVPA/day −33.5 (−46.9,−20.2) At b50 min MVPA/day −6.7 (−10.0,−3.5)
at ≥25 min MVPA/day 0.5 (−3.1, 4.2) At 50–b130 min MVPA/day 2.3 (−0.3, 4.9)
At ≥130 min MVPA/day 3.0 (−7.6, 13.6)
additional 30 min SB/day 1.7 (−2.8, 6.2) 2.0 (−0.2, 4.1)
Model 7
Additional 10 min MVPA/day at b25 min MVPA/day −30.6 (−44.3,−16.9) At b50 min MVPA/day −6.7 (−9.7,−3.7)
at ≥25 min MVPA/day −0.4 (−3.5, 2.8) At 50–b130 min MVPA/day 1.1 (−1.4, 3.6)
At ≥130 min MVPA/day 2.8 (−7.7, 13.4)
Additional 30 min LPA/day at b3 h LPA/day −8.5 (−18.7, 1.7) At b2.5 h LPA/day −11.5 (−18.1,−5.0)
at ≥3 h LPA/day 1.1 (−4.8, 7.0) At 2.5–b5 h LPA/day 0.4 (−2.6, 3.4)
At ≥5 h LPA/day −2.9 (−12.1, 6.2)
Estimates provided are percentage differences (95% CI) in biomarker levels for speciﬁed increases in physical activity or sedentary time parameter, derived from linear regression analyses.
Bold text indicates differences which are statistically signiﬁcant (p b 0.05).
All coefﬁcients adjusted for average daily accelerometerwear time, season ofwear, hour of blood sampling, region of residence, age, social class, living alone, tobacco, alcohol consumption.
SB, sedentary behaviour, LPA, light physical activity, MVPA, moderate and vigorous physical activity.
NT-proBNP, N-terminal pro-brain natriuretic peptide, hsTnT, high sensitivity Troponin.
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was associatedwith a lower risk of all-causemortality, with an adjusted
hazard ratio of a similarmagnitude; 0.94 (95% CI 0.90, 0.98) for each ad-
ditional 1000 steps [25], but howmuch the beneﬁts of physical activity
are mediated via cardiac biomarkers requires further exploration.
In our study, the associations between sedentary behaviour and NT-
proBNP or hsTnT did not persist when moderate/vigorous activity was
included in the model, whereas associations with moderate/vigorous
activity were little affected, suggesting that moderate/vigorous activity
is the important factor for these biomarkers, with light activity also
playing a role for hsTnT. Previous studies have shown obesity to be re-
lated to abnormal cardiac remodeling [26] and impaired myocardial
contractile function [26] as well as higher hsTnT levels [27,28]. The
pathways are not yet fully deﬁned but adjusting relationships between
physical activity/sedentary behaviour and hsTnT for BMI in our data did
not greatly affect coefﬁcients, suggesting that any effect of physical ac-
tivity may be at least partially independent of BMI [29]. Adjusting for
BMI did not change relationships between physical activity/sedentary
behaviour and NT-proBNP in our study, again suggesting a possible in-
dependent role for physical activity. Excluding men with high NT-
proBNP levels (N400 pg/L) indicating potential heart failure reduced
the magnitude of associations but did not change the overall ﬁndings
of our study. Post hoc analysis showed that the associations between
physical activitymeasures andNTproBNPwere present inmenwith hy-
pertension but not in men with normal blood pressure. Possibly in the
hypertensive group men who have higher NTproBNP are those with
early symptoms of diagnosed or undiagnosed heart failure who get
out of breath and therefore are less physically active, and/or the reduced
sample size of men with normal blood pressure (n = 357) may limit
power to detect associations. Given this was a post hoc analysis, this
ﬁnding requires further study.5. Strengths and limitations
Whilst the main limitation of our study is the cross-sectional design
which means we cannot infer causality, a major strength is the use of
objectively measured physical activity, which allowed us to investigate
in detail the shape of the relationship between activity and biomarkers
of cardiac injury, and to explore activity of different intensities including
sedentary behaviour. Participantswere highly compliantwith the accel-
erometer wear protocol; 96% of men provided the ≥5 days data needed
to predict habitual physical activity/sedentary behaviour [30]. Seden-
tary behaviour usually refers to time spent sitting, and we recognise
that the Actigraph accelerometer does not differentiate well between
sitting and standing during periods of b100 cpm. However, mean count
levels for these minutes were b10 cpm indicating that these minutes
were very sedentary. Our study utilises data from an understudied older
age group, and has the advantage of being population based rather than
conﬁned to an at risk group, but results may not be generalizable to
younger age-groups, women or non-European ethnic groups. The study
sample remains socially representative of the UK [31] although men
whoparticipated in our studywere healthier (slightly younger and slight-
ly lower BMI) than those who did not. Given the large range in physical
activity and levels of biomarkers amongparticipantswewouldnot expect
associations between activity and biomarkers to be inﬂuenced by this
selection effect.
6. Conclusions
Our study identiﬁed non-linear relationships between accelerome-
ter measured physical activity and both NT-proBNP and hsTnT, such
that higher levels of total activity, moderate/vigorous activity and light
activity were associated with lower levels of biomarkers at low/
327T.J. Parsons et al. / International Journal of Cardiology 254 (2018) 322–327moderate levels of activity. Higher levels of sedentary behaviour were
associated (linearly) with higher levels of biomarkers, but not indepen-
dently of moderate/vigorous activity. Physical activity may be more
important in protecting against subclinical cardiac ischaemia or myo-
cardial stress and injury in less active individuals and this might be
part of the mechanism by which physical activity protects against a de-
terioration in cardiac health which leads to clinical heart failure and
CVD. However, conﬁrmation in other prospective studies is needed.
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